Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab and Bevacizumab in Esophageal Carcinoma
NCT00636298Phase 2Withdrawn
- Sponsor
- Emory University
- Start
- Oct 2008
- Primary completion
- Mar 2010
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of bevacizumab in esophageal carcinoma, sponsored by Emory University. Planned start Oct 2008; status: withdrawn.
02
Drugs
bevacizumab
03
Conditions
esophageal carcinoma
Beyond the preview
Go deeper on NCT00636298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00636298.